\
Medical Advocates
Enfuvirtide [T-20] (Fuzeon)
 
Main Page

New and Noteworthy
 Corporate Fuzeon Web
 Database of ARV Drug Interactions
 Guidelines
 Journal Data
 Conference Data
Perinatal  Data
 Pediatric Data
ARV Drugs Main Page Main New/Newsworthy  Home Page      
This web page is best viewed by using INTERNET EXPLORER
Last Update:  April 05, 2016
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Read
New and Noteworthy
     
April 2016
 
 
Perinatal Data
       
  Journal Papers, Abstracts and Commentates
 
 
Pharmacokinetic profile in late pregnancy and cord blood concentration of tipranavir and enfuvirtide.
 Weizsaecker K, Kurowski M, Hoffmeister B, et al
Int J STD AIDS. 2011 May;22(5):294-5.
 Abstract

FULL-TEXT ARTICLE
 HIV-1 Fusion Inhibitor Peptides Enfuvirtide and T-1249 Interact with Erythrocyte and
Lymphocyte Membranes.
 Matos PM, Castanho MA, Santos NC.
PLoS One. 2010 Mar 23;5(3):e9830
 Paper

Use of enfuvirtide in pregnancy in HIV positive women in seven cases.
Jeantils V, Alloui C, Rodrigues A, et al
 Gynecol Obstet Fertil. 2009 Apr 22.
 Abstract

Use of darunavir and enfuvirtide in a pregnant woman.
 Sued O, Lattner J, Gun A, Patterson P, et al  
Int J STD AIDS. 2008 Dec;19(12):866-7.
 Abstract
 
Successful prevention of multidrug resistant HIV mother-to-child transmission with enfuvirtide
use in late pregnancy.
 Madeddu G, Calia GM, Campus ML, et al 
Int J STD AIDS. 2008 Sep;19(9):644-5.
 Abstract

Placental transfer of enfuvirtide in the ex vivo human placenta perfusion model.
 Ceccaldi PF, Ferreira C, Gavard L, et al
 Am J Obstet Gynecol. 2008 Jan 31
Abstract

Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with
virological breakthrough.
 Meyohas M-C, Lacombe M, Carbonne B, et al
 AIDS. 18(14):1966-1968, September 24, 2004.
Letter
 
Biojector
       
  Journal Papers, Abstracts and Commentates
 
 
An Open-Label Safety Study of Enfuvirtide Injection with a Needle-Free Injection Device or Needle/Syringe:
The Biojector 2000 Open-Label Safety Study (BOSS).
 Lalezari JP, Saag M, Walworth C, Larson P.
 AIDS Res Hum Retroviruses. 2008 May 28.
 Abstract

A WEEK-IN-REVIEW FEATURED REPORT
Enfuvirtide plasma levels and injection site reactions using a needle-free
gas-powered injection system (Biojector).
 Harris M, Joy R, Larsen G, Valyi M, et al
AIDS. 2006 Mar 21;20(5):719-23.
Abstract

ARV Drugs Main Page Main New/Newsworthy  Home Page      

Enfuvirtide